Related Experiment Video

Updated: May 9, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

Recent advances in small molecule prodrugs for cancer therapy

Peng Wang, Xiao Jin, Jin Cai

  • 1School of Biological Science & Medical Engineering, Southeast University, Nanjing 210096, P.R. China. jimin@seu.edu.cn.

Anti-Cancer Agents in Medicinal Chemistry
|July 23, 2013
PubMed

Insights

Researchers reviewed efficient anticancer prodrugs, focusing on small molecules. These prodrugs improve drug delivery and efficacy for metastatic cancers, overcoming poor druggability challenges in chemotherapy.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Chemotherapy is a primary treatment for metastatic cancers, but its effectiveness is limited by poor drug druggability.
  • Developing potent anticancer drugs is challenging due to the inability of numerous compounds to be effectively formulated or delivered.
  • Prodrug strategies offer a solution by enhancing the delivery and efficacy of therapeutic agents.

Purpose of the Study:

  • To review recently developed, efficient anticancer prodrugs.
  • To focus on small-molecule prodrugs as a key area of advancement.
  • To categorize and summarize these prodrugs based on chemical structure and properties.

Main Methods:

  • Literature review of recent advancements in anticancer prodrug research.
  • Identification and selection of efficient small-molecule anticancer prodrugs.
  • Classification of prodrugs based on chemical structures and properties.

Main Results:

  • Significant progress has been made in the design and synthesis of small-molecule prodrugs for cancer therapy.
  • Various chemical structures and properties of efficient anticancer prodrugs have been identified and summarized.
  • The review highlights the potential of prodrugs to overcome limitations of conventional chemotherapy.

Conclusions:

  • Small-molecule prodrugs represent a promising strategy to enhance anticancer chemotherapy efficacy.
  • Further development and application of these prodrugs can improve treatment outcomes for metastatic cancers.
  • Understanding prodrugs' chemical diversity is crucial for future drug discovery efforts.

Related Concept Videos

Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...